Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169802 · ClinicalTrials.gov registry record
Study Evaluating Retinal Health Monitoring System Visual Acuity Module.
A clinical trial of Age-related Macular Degeneration, sponsored by Kubota Vision.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04169802: Completed study of Age-related Macular Degeneration, sponsored by Kubota Vision.
NCT04169802 is a study of Age-related Macular Degeneration that has completed, run by Kubota Vision. The registered enrollment target is 25 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04169802, a study of Age-related Macular Degeneration, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the performance and usability of the RHMS Visual Acuity Module.
Primary Outcome
To determine the precision (repeatability and reproducibility) of corrected near visual acuity (CNVA) measured by the RHMS Visual Acuity Module and an in-clinic, near logarithmic Sloan Letter chart (Reference Chart).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Retinal Health Monitoring System Visual Acuity Module
- DIAGNOSTIC_TEST Sloan letter, logarithmic near visual acuity chart (Reference Chart)
Study Locations (1)
Arizona
- Retina Consultants of Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2020-04-15 |
What the finished NCT04169802 record still lists
NCT04169802 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Retinal Health Monitoring System Visual Acuity Module is the first listed.
NCT04169802 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04169802 about?
NCT04169802 is a clinical study titled "Study Evaluating Retinal Health Monitoring System Visual Acuity Module.". Assess the performance and usability of the RHMS Visual Acuity Module.
What is the current status of trial NCT04169802?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2019-11-20. Estimated completion is 2020-04-15.
What conditions does trial NCT04169802 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration.
What interventions are being tested in trial NCT04169802?
The interventions under investigation include: Retinal Health Monitoring System Visual Acuity Module (DIAGNOSTIC_TEST), Sloan letter, logarithmic near visual acuity chart (Reference Chart) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04169802?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04169802 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04169802's enrollment target sits among peer trials
25 62nd of 74 higher than 12 of 74 other Age-related Macular Degeneration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Macular Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI